Clinical Trial Update: EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for EUROPAC-2 evaluating pain treatment in hereditary and idiopathic pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: University Medicine Greifswald | Conditions: Pancreatitis | Phase 3 | Status: COMPLETED